Bioactivity:

JNJ-26990990 is a broad-spectrum anticonvulsant drug as a second-generation followup to the marketed drug topiramate. It was designed to have the same anticonvulsant effects as topiramate, but without the side effects associated with topiramate's carbonic

CAS nr:

877316-38-6

Purity:

98%

Molecular Weight:

242,32

SMILES:

O=S(NCC1=CSC2=CC=CC=C21)(N)=O

Formula:

C9H10N2O2S2

Pathway:

Others

Target:

Others